During the past decade, The Neurology Research Group conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 5 clinical trials were completed, i.e. on average, 31.3% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 5 clinical trials were completed. i.e. 62.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Neurology Research Group" #1 sponsor was "Pfizer" with 3 trials, followed by "Eli Lilly and Company" with 2 trials sponsored, "Otsuka Pharmaceutical Development & Commercialization, Inc." with 2 trials sponsored, "AEON Biopharma, Inc." with 1 trials sponsored and "AZTherapies, Inc." with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Neurology Research Group" #1 collaborator was "APCER Life Sciences" with 1 trials as a collaborator, "Alzheimer's Association" with 1 trials as a collaborator, "Clinilabs, Inc." with 1 trials as a collaborator, "ICON Clinical Research" with 1 trials as a collaborator and "KCAS Bio" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "The Neurology Research Group" are "Alzheimer Disease" (2 trials), "Alzheimer's Disease" (2 trials), "Migraine" (2 trials), "Agitation in Participants With Dementia of the Alzheimer's Type" (1 trials) and "Agitation in Patients With Dementia of the Alzheimer's Type" (1 trials). Many other conditions were trialed in "The Neurology Research Group" in a lesser frequency.

Most popular intervention types in "The Neurology Research Group" are "Drug" (16 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "15mg T3D-959" (1 trials), "30 mg T3D-959" (1 trials), "45 mg T3D-959" (1 trials) and "ABP-450" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Neurology Research Group" are 16 trials for "All" genders.

Currently, there are NaN active trials in "The Neurology Research Group". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 8 completed trials in The Neurology Research Group, 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in The Neurology Research Group, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".